Herpes Research Today is a free monthly online journal that collates and summarizes the latest research about Herpes, including details on herpes simplex virus (hsv), genital, oral, symptoms, treatment.

Volume 3 (2006), Issue 3 (March)

1. The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic.
   J Infect Dis, 193(7): 905-11. [Abstract] [Full-text]
2. Impact of the interaction between herpes simplex virus type 1 regulatory protein ICP0 and ubiquitin-specific protease USP7 on activation of adeno-associated virus type 2 rep gene expression.
   J Virol, 80(7): 3650-4. [Abstract] [Full-text]
3. Herpes simplex virus type 1 accumulation, envelopment, and exit in growth cones and varicosities in mid-distal regions of axons.
   J Virol, 80(7): 3592-606. [Abstract] [Full-text]
4. ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection.
   J Virol, 80(7): 3567-81. [Abstract] [Full-text]
5. ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.
   J Virol, 80(7): 3360-8. [Abstract] [Full-text]
6. State and role of SRC family kinases in replication of herpes simplex virus 1.
   J Virol, 80(7): 3349-59. [Abstract] [Full-text]
7. Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1.
   J Virol, 80(7): 3341-8. [Abstract] [Full-text]
8. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.
   J Virol, 80(7): 3293-300. [Abstract] [Full-text]
9. Herpes simplex virus gE/gI must accumulate in the trans-Golgi network at early times and then redistribute to cell junctions to promote cell-cell spread.
   J Virol, 80(7): 3167-79. [Abstract] [Full-text]
10. Enhancement of Th2 responses to replicative herpes simplex virus type 1 vectors by immunomodulative chemotherapy.
    Int Immunopharmacol, 6(5): 817-29. [Abstract] [Full-text]
11. In vivo enhancement of herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibition.
    Int J Cancer, 118(11): 2907-10. [Abstract] [Full-text]
12. Rose bengal and lissamine green inhibit detection of herpes simplex virus by PCR.
    Am J Ophthalmol, 141(4): 756-8. [Abstract] [Full-text]
13. The products of the herpes simplex virus type 1 immediate-early US1/US1.5 genes downregulate levels of S-phase-specific cyclins and facilitate virus replication in S-phase Vero cells.
    J Virol, 80(8): 4005-16. [Abstract] [Full-text]
14. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.
    J Virol, 80(8): 3985-93. [Abstract] [Full-text]
15. Stable association of herpes simplex virus with target membranes is triggered by low pH in the presence of the gD receptor, HVEM.
    J Virol, 80(8): 3773-80. [Abstract] [Full-text]
16. U(S)3 and U(S)3.5 protein kinases of herpes simplex virus 1 differ with respect to their functions in blocking apoptosis and in virion maturation and egress.
    J Virol, 80(8): 3752-64. [Abstract] [Full-text]

© 2004-2008 Herpes Research Today. All Rights Reserved.